Mini Symposium: Respiratory Syncytial Virus and Other Respiratory Infections
Monday, November 6th, Antwerpen, Belgium
| Timing | Title | Presenter |
| 18.00 | Opening Symposium: Revirant/Respiratory Infections@UAntwerpen – RSV awareness week – Pediatric Clinical Trial Network | Prof. Stijn Verhulst, MD & Prof. Peter Delputte |
| 18.15 | RSV Surveillance: Tools and Usefulness | Dr. Cyril Barbezange |
| 18.30 | The role of co-infections in RSV disease severity | Kim Stobbelaar, MD |
| 18.45 | Update on maternal RSV vaccines | Prof. Kirsten Maertens |
| 19.00 | Update MSD's development in RSV prevention | Jessica Vandenhaute, PhD |
| 19.15 | CHIM studies for development of respiratory vaccines | Bart Van Meerbergen, PhD |
| 19.30 | Update Sanofi on Nirsevimab | Linda Vercammen |
| 19.45 | Update GSK: RSV vaccination in older adults | Jeroen Dekeye |
| 20.00 | Topical microbial therapeutics against RSV and other respiratory viruses | Prof. Irina Spacova |
| 20.15 | Moderna – mRNA vaccines against RSV in older adults and pediatric patients | Vincent Lempers, PharmD, PhD |
| 20.30 | Pfizer: Protecting infants against RSV through maternal immunization | Machteld De Bock, MD |
| 20.45 | RSV disease in children with comorbidities | Prof. Kim Van Hoorenbeeck, MD |
| 21.00 | Closing remarks and Pediatric Trial Network Chair | Prof. Stijn Verhulst, MD |
|
| Reception |
|